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Abstract
Staphylococcal infections are reported to cause very important problems in hospital‐
ized and immunocompressed patients worldwide due to their tough and irresponsive
treatment by antibiotics. Biofilm-embedded bacteria that gain resistance to immune
defense and antibiotics by antibiotic degrading enzymes, efflux pumps, and certain gene
products of which expression are changed by the quorum sensing cause chronic and
recurrent infections such as indwelling device–associated infections. Biofilm-embed‐
ded sessile  community  has  heterogeneous  cells  that  have  wide  range  of  different
responds  to  each  antimicrobials.  Staphylococcus  epidermidis  (S.  epidermidis)  and
Staphylococcus aureus (S. aureus) that are mostly known pathogenic strains can induce
gene expression of biofilm that has an important role in the pathogenesis of staphylo‐
coccal infections and causes bacterial attachment and colonization on biotic such as
tissues or abiotic surfaces such as prosthetic surfaces that may act as a substrate for
microbial  adhesion  when  microorganisms  exposed  to  stress  conditions.  This  ex‐
pressed and matured biofilm causes bacterial spread to whole body, consequently,
spread of infection in to whole body. It is hard to treat biofilm infections, and new agents
are being researched to prevent formation and dissemination of biofilm. Defining the
virulence and the role of biofilm of S. epidermidis and S. aureus in chronic and recur‐
rent infections such as indwelling device–associated infections, the mechanism and the
global  regulation of biofilm production by quorum-sensing system, inactivation of
biofilm formation, and the resistance patterns of biofilm-embedded microorganism
against antimicrobials are important.
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
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1. Introduction
Staphylococcus epidermidis (S. epidermidis) and Staphylococcus aureus (S. aureus) are the most
common causes of indwelling device–associated infections, and nosocomial and community
acquired infections can produce biofilm as a virulence factor [1]. The biofilm infections such
as S. epidermidis and S. aureus infections are important problems in hospitalized and immu‐
nocompressed patients worldwide due to their tough and irresponsive treatment by antibi‐
otics.  Biofilm-producing  bacteria  resist  to  immune  defense,  antibiotics,  and  many
antimicrobial  agents.  Biofilm-embedded  bacteria  gain  antibiotic  resistance  by  antibiotic-
degrading enzymes, efflux pumps, and certain gene products of which expression are changed
by the quorum sensing [2, 3]. Biofilm-embedded sessile community has heterogeneous cells
that have wide range of different responds to each antimicrobials [2]. So, every antibiotic has
a different effect against different metabolically active cells that are present in the different
layers of biofilm and persister cells that are evolved to survive in biofilm. It is hard to treat
biofilm infections that are generally recurrent infections and of which treatments are tough
and irresponsive [3].
Staphylococci that construct the human skin flora can contaminate indwelling devices. By this
way, they are inserted to human by contaminated indwelling devices. When microorgan‐
isms exposed to stress conditions, gene expression of biofilm is induced as a stress response.
The biofilm that is a slime-like glycocalyx causes bacteria to survive in the stress conditions.
Staphylococci adhere, colonize, and infect biotic surfaces such as tissue or abiotic surfaces such
as prosthetic surfaces that may act as a substrate for microbial adhesion and causes bacterial
spread to whole body by forming biofilm that is a slime-like glycocalyx [1, 4, 5]. The viru‐
lence and the role of biofilm of S. epidermidis and S. aureus in chronic and recurrent infec‐
tions such as indwelling device–associated infections, the mechanism, and the global
regulation of biofilm production by quorum-sensing system, especially agr-quorum-sensing
system, inactivation of biofilm formation, and the resistance patterns of biofilm-embedded
microorganism against antimicrobials are discussed in this chapter.
2. The biofilm, virulence, and Staphylococcus
2.1. The pathogenesis of Staphylococcus biofilm
The biofilm has an important role in the pathogenesis of staphylococcal infections. The biofilm
causes bacteria to survive in the stress conditions such as UV damage, metal toxicity, anaero‐
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bic conditions, acid exposure, salinity, pH gradients, desiccation, bacteriophages, and amoebae
and to resist antibiotics, antimicrobials, and host immune defense [5–8]. The main pathogen
of implant infections is staphylococci that cause 80% of all prosthetic infections [9]. The biofilm
of bacteria causes chronic infections such as indwelling device–related infections, chronic
wound infections, chronic urinary tract infections (UTI), cystic fibrosis pneumonia, chronic
otitis media (OM), chronic rhinosinusitis, periodontitis, and recurrent tonsillitis [10]. The
biofilm infections are the main important problems in hospitalized and immunocompressed
patients in worldwide due to their tough and irresponsive treatment by antibiotics. In biofilm,
bacteria are not distrupted completely by antibiotics even high doses of antibiotics used in vivo
[3, 11, 12]. Infected device can expose the patient to a higher risk of mortality. Orthopedic
surgery and trauma indwelling device-related infections that make treatment difficult by
antibiotics [13] cause removal of implant out of the body to eradicate biofilm and overcome
biofilm-related infections [14] and may cause functional loss of the infected limb [15, 16].
2.2. Staphylococcal biofilms as a virulence factor
The biofilm that anchored to abiotic or biotic surfaces is a slime-like glycocalyx in which sessile
community of microorganisms embedded. This extracellular polymeric substance that is
constituted by matrix of polysaccharide, teichoic acids, extracellular DNA (eDNA), and
staphylococcal proteins is produced by biofilm producing microorganisms [4, 17, 18].
Polysaccharide intracellular adhesin (PIA) is a specific polysaccharide in glycocalyx com‐
posed of β-1,6–linked N-acetylglucosamine residues (80–85%) and non-N-acetylated D-
glucosaminyl residues that are an anionic fraction and contain phosphate and ester-linked
succinate (15–20%) [18]. Although PIA is a main mechanism of biofilm formation in S. aureus
and S. epidermidis, surface proteins are the other alternative mechanism of biofilm formation.
Extracellular matrix has large water-filled channels, accumulates antibiotic-degrading
enzymes such as β-lactamases [19], and plays a role in the adaptive resistance mechanisms
due to eDNA constituent [20] (Figure 3).
2.3. Mechanisms of biofilm formation
Bacterial biofilm formation is a complex and multifactorial process. The biofilm formation
process consists of adherence/adhesion/attachment, aggregation/maturation/accumulation,
and detachment/dispersal phase. The last step is the dispersal of mature biofilm-embedded
bacteria out of the biofilm [21] (Figure 1).
2.3.1. Attachment (adhesion or adherence) phase
When conditions favor biofilm formation, biofilm formation that begins with the adherence
of the bacteria to a surface that act as a substrate for microbial adhesion continues with the
aggregation formed by cell–cell adhesion [22] (Figure 1).
Staphylococcal adherence to an abiotic surface of indwelling prosthetic device depends on
physico-chemical structure of medical device and surface components of Staphylococci such
as wall teichoic acid (WTA) [23], lipoteichoic acid (LTA) [23], accumulation-associated
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protein (Aap) [24], autolysins AtlA [25] and AtlE [26]. The staphylococcal adherence to a biotic
surfaces such as host cells and plasma protein-coated prosthetic surface is mediated by cell
wall-anchored (CWA) proteins such as the fibrinogen-binding protein SdrG/Fbe of S.
epidermidis and fibrinogen-/fibronectin-binding proteins FnBPA and FnBPB and clumping
factors A and B of S. aureus [27].
Several microbial surface components recognizing adhesive matrix molecules (MSCRAMMs)
that are able to bind to human matrix proteins such as fibronectin and fibrinogen and colonize
are expressed in S. epidermidis and S. aureus at the first step [28]. Adherence of bacteria to an
extracellular matrix component, fibronectin, fibrinogen, and plasma clot is mediated by
expressed surface adhesins such as Bap coded by bap gene [29], surface protein G (SasG) [22],
fibronectin-binding proteins (FnbA and FnbB) of S. aureus [30], and the fibrinogen-binding
protein SdrG/Fbe of S. epidermidis [27]. Adherence of S. aureus to collagenous tissues and
cartilage is mediated by collagen-binding protein, Cna. Some antibodies can block bacterial
attachment to these tissues by blocking Cna. Adherence of S. aureus to fibrinogen in the
presence of fibronectin is mediated by clumping factor A and B (ClfA, ClfB) that are effec‐
tive in foreign body and wound infections. Also, plasma-sensitive surface protein (Pls)
participates in the attachment to fibrinogen and fibronectin. Protein A that is present in cell
wall and encoded by spa gene in S. aureus impair opsonization and phagocytosis by binding
to Fc domain of immunoglobulin G (IgG) in the wrong orientation. Endovascular diseases are
emerged by S. aureus as a result of the binding of protein A to von Willebrand factor in damaged
endothelium [31].
Figure 1. The stages of biofilm formation.
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2.3.2. Accumulation (aggregation or maturation) phase
After adherence of staphylococcus to biotic and abiotic surfaces, exopolysaccharide (EPS) such
as PIA or PNAG that are produced by ica operon (ica-dependent form) starts to be produced,
extracellular matrix (ECM) is constructed by PIA/PNAG, extracellular DNA (eDNA), and
surface proteins [cell wall-anchored (CWA) proteins] in ica-independent form, and bacterial
colonies become mature [2, 27]. The cell wall-anchored (CWA) proteins not only provide
bacterial adherence but also provide intercellular adhesion, biofilm accumulation, and
maturation [27]. Aggregation that is mediated by the synthesis of either polysaccharide
intercellular adhesion/poly-N-acetylglucosamine (PIA/PNAG) [30, 32] is formed in cell
clusters till multi-layer-structured biofilms formed. Several staphylococcal surface proteins
that mediate primary attachment of bacteria such as clumping factors A and B, fibrinogen-/
fibronectin-binding proteins FnbA and FnbB of S. aureus or the fibrinogen-binding protein
SdrG/Fbe of S. epidermidis that are cell wall-anchored proteins (CWA) also promote intercel‐
lular adhesion and construct the aggregation of bacteria in ica-independent biofilm forma‐
tion rather than PIA [33] (Figure 1).
In the initial cell-surface interaction of motile bacteria, adherence of motile cell to surface is
facilitated by flagella of motile cell. After adherence motile species that undergo cellular
differentiation in biofilm lose their motility by paralyzing their flagella and become nonmo‐
tile [34]. Klausen et al. [35] revealed that wild-type strain and isogenic flagellar mutant of
Pseudomonas aeroginosa both forms biofilms which have structural differences.
2.3.3. The detachment (or dispersal) phase
In the detachment stage, sessile cells turn into planktonic state that can spread and colonize
other surfaces and form biofilm on these infected regions [2] (Figure 1). Detachment of
microorganisms from biofilm can be caused by bacteria themselves, such as enzymatic
degradation of the biofilm matrix such as dissolution of adhesins by proteases, nucleases, and
a group of small amphiphilic α-helical peptides, known as phenol-soluble modulins (PSMs)
functioning as surfactants [27], and quorum sensing or by external forces such as fluid shear
forces, corrosion, and human intervention [36] (Figure 2). During detachment of motile
microorganism rather than staphylococcus, cells express genes that are for motility such as
transcription of pilus and ribosomal proteins and are almost seen in planktonic cells [37].
2.4. Types of biofilm formation
2.4.1. PIA-dependent biofilm formation
Positively charged PIA provides intercellular attachment via binding to bacteria of which
surface is negatively charged [27]. All S. aureus strains contain icaADBC gene of which product
is PIA constructs biofilm formation [31]. Ica locus have been identified in many staphylococ‐
cus species like S. aureus and S. epidermidis but except S. haemolyticus and S. saphrophyticus [9].
ica is regulated by stress conditions, such as anaerobic conditions, extreme temperature,
osmolarity, ethanol, and antibiotics. icaA, icaD, icaC, and icaB are the genes of icaADBC locus.
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icaA and icaD contribute to exopolysaccharide synthesis and encode N-acetylglucosaminyl
transferase as a transmembrane enzyme to synthesize poly-N-acetylglucosamine polymer.
While poly-N-acetylglucosamine polymer is translocated to cell surface of bacteria by icaD
gene, the polymer is fixed to the outer surface of bacteria by deacylation of poly-N-acetylglu‐
cosamine polymer by the product of icaB gene [9]. Regulator gene icaR that is located up‐
stream of the icaADBC operon encodes a transcriptional repressor in both S. epidermidis and S.
aureus and icaADBC genes are upregulated in response to anaerobic growth such as inside of
biofilm. Under anaerobic conditions, PIA is induced by SrrAB (the staphylococcal respirato‐
ry response regulator) that binds to upstream of the icaADBC operon. Insertion sequence
(IS256) can regulate ica by reversible inactivation in S. epidermidis and some strains of S. aureus.
TcaR (transcriptional regulator of the teicoplanin-associated locus) and IcaR are repressors of
ica operon transcription and repress PIA expression. While deletion of icaR gene increases ica
gene expression, PIA production, deletion of tcaR gene had no effect against ica gene, PIA
production. Transcription of IcaR is repressed by Rbf that is a protein regulator of biofilm
formation and leads expression of ica gene, PIA production, whereas transcription of IcaR is
induced by Spx that is a global regulator of stress response genes and regulates biofilm
formation negatively [18].
2.4.2. PIA-independent biofilm formation
Biofilms not only can be constructed by ica gene of which product is PIA, but also construct‐
ed by ica-independent (PIA-independent) form. Biofilm is generated not only by PIA that is a
main component of biofilm production but also by a number of proteins. When icaADBC is
deleted, PIA is not produced but the biofilm formation so, virulence is not affected. In this case,
biofilm formation can be constructed rather than PIA. In the catheter infection, biofilm
formation of clinical isolates of S. aureus of which ica cluster is mutated is not reduced [18].
Fitzpatrick et al. revealed that biofilm formation of the icaADBC operon-deleted MRSA
mutants was not affected, whereas biofilm formation of the icaADBC operon-deleted MSSA
mutants was impaired. This study showed that ica-independent biofilm formation is strain
specific [38].
PIA-independent biofilms were constructed by accumulation-associated proteins (Aap) of S.
epidermidis, biofilm-associated protein (Bap) that is a surface protein of S. epidermidis and S.
aureus and Bap-related proteins of S. aureus [18]. Other surface proteins that involve in the PIA-
independent biofilm formation are SasG, SasC, protein A, fibronectin-binding proteins FnBPA
and FnBPB, cell wall-anchored (CWA) proteins including clumping factors A and B, autoly‐
sins AtlA and AtlE or wall teichoic acid (WTA), the fibrinogen-binding protein SdrG/Fbe,
lipoteichoic acids (LTA) of S. aureus and the fibrinogen-binding protein SdrG/Fbe of S.
epidermidis [27].
Scientists determined that medical MRSA isolates produce protein-dependent biofilm such as
FnBP- and Aap-dependent biofilms in animal models that have indwelling device–associat‐
ed infection. O’Neill et al. [30] and McCourt et al. [39] revealed that biofilms of certain isolates
of HA-MRSA from CC8 and CC22 and CA-MRSA from USA300 lineage (CC8) were FnBPs-
dependent.
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Autolysin Atl that is a wall-anchored protein of S. aureus and causes initial attachment of S.
aureus to surfaces can be cleaved into amidase and glucosaminidase that cause cell lysis, eDNA
release, and cell accumulation. Then, biofilm maturation of FnBP-dependent biofilm pheno‐
type is constructed by FnBPs [25].
In biofilm production of S. aureus, cell-cell interactions are facilitated by α-toxin that is a
haemolytic toxin. Nevertheless, the mechanism of integral role of α-toxin has not been known
clearly. β-toxin that is a sphingomyelinase and causes hemolysis and lyse lymphocytes plays
a stimulative role in the biofilm production of S. aureus by covalently cross-linking to itself in
the occurrence of DNA in matrix of staphylococcal biofilms [40].
S. aureus biofilms can be stabilized by amyloid fibrils that are formed by aggregated PSM on
the surface of bacteria and aggregated signal peptide AgrD [41].
2.5. The global regulation of biofilm formation
2.5.1. The regulation of Staphylococcal biofilm by agr-quorum-sensing system
Biofilm production is provided by the equilibrium between the productions of amyloid fibrils
and phenol soluble modulins (PSMs) that are extracellular polymeric substances and their
catabolism by enzymes such as nucleases and proteases that are expressed by agr-QS regulator
system that use two-component system signal transduction system (TCS). The control of
planktonic and sessile bacteria and the biofilm expression is regulated by coordinated
mechanisms [41] (Figure 2).
Figure 2. The regulation of biofilm formation by agr-quorum-sensing system.
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The biofilm formation of staphylococci is fully expressed in vivo, whereas the biofilm forma‐
tion of staphylococci is not fully expressed all the time in vitro unless nutrient supplementa‐
tions are added to growth media and is provided. Increased amount of biofilm formation due
to fully expression occurs in stress conditions such as starvation, thermal stress, heat shock,
salt, certain antibiotics, iron limitation, subinhibitory concentrations of ethanol, accumula‐
tions of metabolites, oxidative stress, low pH, and changes in osmolarity in vitro. Bacteria sense
stimuli from the environment and bacterial density and then respond to stimuli by upregu‐
lating expression of biofilm formation, virulence factors production such as toxins, etc. [9].
Staphylococcus use quorum-sensing systems (QS) for intercellular communication and biofilm
formation. Accessory gene regulator (Agr) system regulates cell density-dependent gene
expression using two-component signal transduction system [42]. Agr and LuxS systems that
are required for autoinducer peptide (AIP) production as a pheromone are quorum-sensing
systems in staphylococci [43]. Bacteria sense pheromones as stimuli that are released by the
density of bacteria belonging to the same group and express biofilm formation [9]. AIP
production starts in exponential phase of bacterial growth [44]. There are four proteins that
are sensor histidine protein kinase AgrC, DNA-binding response regulator AgrA, AgrD that
is a prepheromone, and AgrB that exports and modifies AgrD, present in this system. The
signal is transported to bacteria by binding of AIP to AgrC. When AIP binds to AgrC, DNA-
binding regulator AgrA is activated by His-dependent phosphorylation of AgrC [42]. By the
binding of activated DNA-binding regulator AgrA to P2 and P3 promoters in agr operon
(agrBDCA), RNAII and RNAIII are transcripted, respectively [44]. The agrBDCA operon codes
RNAII transcript that encodes AgrB, D, C, A from agrB, D, C, A genes as a components of agr
system, and RNAIII transcript that include hld gene encodes the δ-hemolysin (termed δ-toxin
or δ-PSM) [42]. RNAIII regulates the expression of agr-governed virulence factors such as
CWA proteins as a surface proteins and exotoxins at transcriptional and translational level.
Independently of RNAIII (RNAIII independent control), AgrA also directly regulates the
expression of α-PSMs and β-PSMs by binding to their promoters in psm operon in S. aureus
and involves in the downregulation of genes contribute carbohydrate and amino acid
metabolism [44] (Figure 2).
Figure 3. The biofilm-embedded bacteria. (a) The heterogeneous sessile community of biofilm. (b) Antibiotic resistance
mechanisms of biofilm-embedded bacteria.
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The regulation mechanisms of RNAIII for target genes can be at transcriptional and transla‐
tional level, and its regulation can be direct or indirect. Fourteen stem-loop and two long helices
construct structure of RNAIII. Each domain regulates the expression of each target gene.
Translation of α-hemolysin (hla) upregulated by hairpin loop H2 and H3. In contrast to this,
the repression of early expressed virulence genes of S. aureus such as coagulase, protein A, and
the repressor of toxins (Rot) is comprised by hairpin H13, H14, and H7 of RNAIII. Hairpins
such as H7, H13, and H14 that are complementary to Shine-Dalgarno sequences (SD) of target
mRNA act as an antisense RNA and inhibit initiation of translation and cause RNAaseIII-
mediated degradation of target mRNA [45] (Figure 4).
Figure 4. The structure of RNAIII [44]
Staphylococcal virulence factors are expressed with accessory gene regulator (agr) system in
response to cell density [9]. During the beginning of the biofilm-related staphylococcal
infection, adhesion factors (surface proteins) such as MSCRAMMs are upregulated. After
initial attachment and colonization had been happened, during early stationary growth phase
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of bacteria, toxins and other acute virulence factors such as degradative exoenzymes (such
as δ-hemolysin, lipases and proteases that disperse bacteria) are upregulated and non-
aggressive colonization surface proteins such as MSCRAMMs are downregulated by agr-QS
regulator system [1, 46]. Adherence is reduced by downregulated genes of CWA, due to surface
proteins are no longer needed after colonization, by the way initial biofilm formation is
decreased indirectly [5]. Expression of staphylococcal toxins such as enterotoxin B, toxic shock
syndrome toxin-1, exfoliative toxins, fibrinolysin, α, β, γ, and δ hemolysins, other phenol-
soluble modulins (PSMs), leucocidin, capsular polysaccharide (type 5 and 8), serine protease,
and DNase is increased (upregulated), and expression of surface proteins and biofilm
formation is decreased (downregulated) by agr of S. aureus and S. epidermidis [9, 44]. Infec‐
tion is dispersed to other surfaces by the detachment of biofilm that is caused by the upregu‐
lation of the expression of PSMs that have an important role in acute infection [1]. In chronic
biofilm-associated infection of S. aureus high amount of QS or psm gene mutants are present,
by the way, mutants favor compact biofilm development and biofilm/infection cannot be
dispersed to other surfaces [46, 47].
The production of PIA/PNAG, PIA/PNAG-degrading enzymes, and matrix components of
staphylococcal biofilm is not regulated by QS [44, 46].
Phenol-soluble modulins (PSMs) are surfactant-like staphylococcal peptides and are control‐
led by agr locus function in biofilm maturation, biofilm structuring/destructuring, dispersal,
and dissemination by distruption of non-covalent interactions between biofilm matrix
molecules. PSMs have a role in the pathogenesis of S. aureus and S. epidermidis biofilm-
associated infections [9, 21, 46]. In contrast to soluble PSMs, PSMs that are aggregated form
amyloid fibrils that contribute to stability of the biofilm [27, 41]. S. aureus and S. epidermidis
catheter-related infections can be controlled by PSM surfactant-mediated QS control of
biofilms for biofilm maturation and dissemination [48, 49]. The biofilm maturation is not only
caused by PSM surfactants but also enzymatic degradation of biofilm matrix components by
proteases and nucleases [46]. But Beenken et al. [50] revealed that nuclease did not disperse S.
aureus in vitro. Hochbaum et al. [51] revealed that D-amino acids trigger biofilm dispersal of
S. aureus.
Agr (AIPs) of each strain belongs to different agr classes of which biofilm-forming capacities
and syndromes are different. Four main classes of AIPs (Agr) are present in S. aureus and S.
epidermidis. S. aureus strains of which agr classes are agr II and agr III are high and medium
biofilm formers due to having defective and inactive agr, respectively. Non-defective and
active agr is present in agr I and agr IV strains that are weak biofilm producers [52]. agr IV S.
aureus strains are more associated with exfoliative syndromes. agr I S. aureus strains are isolated
from endocarditis and superficial infections. agr II and agr III S. aureus strains are isolated from
endocarditis and nasal colonization, respectively [53]. Mortality due to agr II–caused infec‐
tions is higher than agr I–caused infections [54]. The prevalences of agr I type among the S.
epidermidis clinical isolates and S. epidermidis localized in skin flora are approximately 89%
and 52%, respectively [55]. The sequences of AIPs that belong to agr I, II, III, and IV classes in
S. aureus and S. epidermidis are YSTCDFTM, GVNACSSLF, YINCDFLL, YSTCYFTM, YNPCA‐
SYL, DSVCASYF, YNPCSNYL, YNPCANYL, respectively [55, 56].
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To control biofilm-associated staphylococcal infections, production of virulence factors and
antibiotic resistance, QS can be disrupted by inhibition of signal production, degrading signals,
and suppressing synthase and receptors [9].
2.5.2. The regulation of Staphylococcal biofilm by other than Agr
2.5.2.1. sarA
Two-component regulator gene locus encoded by arlRS is regulated by agr and sarA loci. sarA
and agr have opposite functions in staphylococcal global regulation. When enough quorum
population is present, at the beginning of attachment phase sarA is upregulated. During the
initial stages, SarA enhances expression of PIA, adhesions, and EPS, by the way, induces
attachment and early biofilm formation. SarA also represses nuclease and protease synthesis.
After attachment of bacteria, agr system works and virulence factors that cause dispersal,
nucleases and proteases and PSMs are produced [18].
2.5.2.2. sigB
The sigB operon of which product is σB in S. aureus upregulates ica transcription, and the factors
for early stages of biofilm formation including FnbpA, clumbing factor, and coagulase and
downregulates factors that are efficient in dispersal and in passing to planktonic state such
as β-hemolysin, enterotoxin B, serine protease (SplA), cysteine protease (SplB), the metallo‐
protease Aur, staphopain, and leukotoxin D [18].
2.5.2.3. ArIRS
The biofilm formation of S. epidermidis [57] and S. aureus [58] can be also regulated by ArIRS
that uses TCS. The biofilm formation of S. epidermidis is regulated by ArIRS in ica-dependent
manner, whereas in S. aureus, this is ica-independent manner [59]. ArlRS also plays a role in
the modulation of bacterial autolysis, as a result of eDNA release that participates in biofilm
matrix [9].
2.5.2.4. lytSR
LytSR operon that is the other TCS of S. aureus plays a role in the activity of murein hydro‐
lase that is an autolysin and distrupt structural components of the bacterial cell wall, conse‐
quently, autolysis. Lrg/cid operon that is a target of this system regulates lysis of cell during
biofilm formation [60]. The regulator LytR that is effected by stimuli bound LytS sensor
histidine kinase protein activates transcription of genes under its control. The regulator LytR
upregulates the expression of lrgA and lrgB genes [61]. Encoded LrgA by lrgA is an antiholin
and inhibits the extracellular activity of murein hydrolases, whereas cidA gene encodes holin
protein that effects the activity of murein hydrolase, consequently, cell lysis and release of
eDNA that participate in biofilm matrix [9].
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2.5.3. Inactivation of ica by sequences
2.5.3.1. IS256
Although S. epidermidis strains are ica positive, they cannot produce biofilm due to IS256
insertion sequence that is inserted within the ica operon. Ziebuhr et al.[62] revealed that if
bacterial genomic DNA contained IS256, IS256 was not seen within ica locus. They also revealed
that although S. epidermidis strains that caused indwelling device–associated infection was ica
positive and the insertion of IS256 is not seen within ica locus, strains did not produce
biofilm (“off switch”) [62]. These results showed that IS256 is not a natural occurring global
regulator mechanism of biofilm production. The similar results were gained for S. aureus. IS256
that was inserted within icaC gene of S. aureus strain prevented biofilm formation by inacti‐
vating icaC gene [63].
2.5.3.2. Tetranucleotide tandem repeat
icaC inactivation caused by the expansion or contraction of tetranucleotide tandem repeat
inhibits PIA/PNAG formation in S. aureus [64]. The reading frame of icaC is shifted by
tetranucleotide tandem repeat (“ttta”), and this contributes premature stop of IcaC protein,
consequently, inhibited PIA/PNAG production (“off switch”). Mutated icaC is preferred for
the indwelling device-associated infections due to off switching of PIA/PNAG production.
2.6. Treatment of biofilm
To provide protection against S. aureus and S. epidermidis biofilm-associated infections vaccine
that causes production of antibodies against PNAG and PSM peptides can be used. Research‐
ers had revealed that mutant S. aureus of which icaB is over-expressed and produces high
amount of surface associated PNAG was more opsonized by antibodies and undergoes to
phagocytosis. But immune response is ineffective antibodies produced against PIA/PNAG of
vaccine bind secreted PIA/PNAG of bacteria rather than surface-associated PIA/PNAG of
bacteria [65]. Conjugate vaccine that contains S. aureus PNAG and clumping factor A can
accelerate immune response [66]. Bacterial dispersal from indwelling medical devices can be
prevented by antibodies against PSM peptides [48]. Brady et al. [67] had treated chronic
osteomyelitis with a combination of antibiotic and quadrivalent vaccine that contains four
antigens, which are glucosaminidase, an ABC transporter lipoprotein, a conserved hypothet‐
ical protein, and a conserved lipoprotein. By this way, Brady et al. [67] had reduced biofilm
formation of S. aureus on infected tibias.
Kaplan et al. [68] and Whitchurch et al. [69] concluded that DNase I in human serum can
degrade eDNA in biofilm matrix, by the way bacterial biofilms are degreased.
Nitric oxide (NO) that is a product of anaerobic respiration can cause dispersal of microor‐
ganism from mature biofilm by stimulation of c-di-GMP phosphodiesterases activity [70]. c-
di-GMP biosynthesis inhibitors can be an alternative treatment for preventing biofilm
formation and mature biofilm dispersal. The combinations of dispersin B (EPS-degrading
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enzymes) and disinfectants such as triclosan with antibiotics that are used in the treatment of
wound and skin infections provides synergistic removal of biofilms [71].
3. The mechanisms of antibiotic resistance in biofilm-embedded
microorganism
Biofilm-embedded bacteria are more resistant to antimicrobial agents than planktonic bacteria.
It is difficult to eradicate biofilm, and this causes serious clinical problem [72].
Antibiotic resistance (tolerance) that is caused by biofilm and permit bacteria to survive is a
physiological state by which mutational changes not caused [73]. Impermeability of peptido‐
glycan by efflux pumps, antibiotic-degrading enzymes, the charge of polymers [73], and
certain gene products that are produced in biofilms [3] are the other antibiotic resistance
mechanisms of bacteria rather than the biofilm [3]. Biofilm can gain higher antibiotic toler‐
ance by antibiotic degrading enzymes such as beta-lactamases, efflux pumps, and certain gene
products of which expression are changed by the quorum sensing as a stress response [3, 74].
Biofilms resist to beta-lactam antibiotics by beta-lactamases. Beta-lactamases that are pro‐
duced by bacteria play a key factor in the biofilm caused resistance to beta-lactam antibiotics
[3].
3.1. The heterogeneous sessile community and the physiology of biofilm
Biofilm-embedded sessile community has heterogeneous cells that are in the different growth
states. Bacterial growth rate is reduced by stress conditions such as nutrient and oxygen
limitation at the lower parts of the biofilm, and low metabolic activity. Low metabolically active
cells (slow growing cells) are seen at the deeper parts of the biofilm, whereas high metabol‐
ically active cells (rapid growing cells) are seen at the surfaces of the biofilm. These heteroge‐
neous cells that consist of low and high metabolically active cells have wide range of different
responds to each antimicrobial. Antibiotic penetration through the biofilm is reduced by
reduced bacterial growth rate. The biofilm-related resistance mechanisms such as oxygen
limitation and low metabolic activity, reduced antibiotic penetration through the biofilm, and
gaining genetic adaptations such as increased changes in the genes of the DNA repair systems
play a key factor in the biofilm tolerance to antibiotics [3]. But some antibiotics such as colistin
are just effective against slow-growing cells seen at the deeper parts of the biofilm not against
rapid growing cells that acquired adaptive resistance by upregulation of the LPS-modifica‐
tion (arn) operon [75]. Persister cell population that is present in the biofilms of S. epidermidis
can withstand to inhibitory concentrations of antibiotics [76] (Figure 3).
3.2. Nutrient limitation
Some researchers demonstrated that nutrient limitation-related antibiotic resistance is not due
to the reduced growth rate of microorganism, but rather to the activation of regulated stress
responses. Nutrient limitation-related antibiotic resistance is controlled by complex regulato‐
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ry pathways [77]. During starvation, the activation of the stringent response participates in
antibiotic resistance such as fluoroquinolone resistance in E. coli biofilms [23]. Also, some
researchers demonstrated that certain efflux pumps in P. aeruginosa are upregulated in the low-
oxygen conditions [78] (Figure 3).
3.3. Biofilm matrix
Usually, the decreased antibiotic penetration through the biofilm is caused by antibiotics that
may bind to the structural contents of biofilm matrix [3] rather than reduced diffusion of
antibiotics through the biofilm matrix [10] (Figure 3).
3.4. Agr expression
Antibiotic susceptibility of biofilm-embedded bacteria decreases according to the planktonic
state. The virulence of agr defective strains is lesser than the wild type. Expression of agr that
imposes a fitness cost on S. aureus effects drug resistance of staphylococcal biofilm. It has been
revealed that RNAIII production (provides fitness cost of bacteria) of agr-positive bacteria is
induced by subletal doses of ciprofloxacin, mupirocin, and rifampin [79]. The adaptability of
S. aureus to antibiotics involves the agr locus. S. aureus resists to drugs by adapting to antibi‐
otics with agr locus. Ciprofloxacin, mupirocin, and rifampin are more effective against agr-
defective bacteria. These antibiotics just must be used in agr-deficient mutants or agr-negative
S. aureus when designing antimicrobial chemotherapy. agr-defective strains are isolated
frequently in hospital-acquired S. aureus (HA-S. aureus) infections. Due to broad antibiotic
usage in hospitals, the prevalence of agr-defective strains among hospital-acquired S. aureus
infections is high and ranges between 15% and 60% [80].
Agr expression of biofilm producer staphylococcus has also been associated with the drug
resistance of some antibiotics. It has been also revealed that the effect of rifampin against agr-
defective S. aureus mutants was increased, whereas the effect of oxacilline unchanged [79]. agr
negative or agr dysfunction strains have a fitness advantage over agr positive strains in the
presence of some antibiotics such as vancomycin. Vancomycin susceptibility is reduced in
VISA (vancomycin-intermediate S. aureus) due to the thickening of cell wall that is the result
of the combination of cell wall biosynthesis activation and decreased autolytic activity. agr
mutations have been correlated with the rise of VISA. agr defects that reduce autolysis decrease
susceptibility of vancomycin of VISA [81].
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